Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

BBH vs GNOM overlap: 23% of top holdings shared

Bottom line

How much do BBH and GNOM overlap?

23% of their top holdings overlap by weight. 8 securities appear in both funds' top 25, making up 38.2% of BBH's assets and 29.1% of GNOM's. They are substantially different portfolios, so owning both adds real diversification.

GNOM holds far more positions (51 vs 25), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

BBHGNOM
Weight overlap (top 25)23%
Shared holdings8
Weight in shared holdings38.2%29.1%
Total positions2551
Expense ratio0.35%0.5%
Holdings as ofJun 30, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Holdings BBH and GNOM have in common

Holding% of BBH% of GNOMOverlap
Gilead Sciences Inc12.79%1.95%1.95%
Vertex Pharmaceuticals Inc9.10%3.95%3.95%
Natera Inc4.92%4.15%4.15%
Moderna Inc3.36%3.28%3.28%
Illumina Inc3.17%4.82%3.17%
BioNTech SE1.94%3.41%1.94%
Bio-Techne Corp1.54%3.41%1.54%
BioMarin Pharmaceutical Inc1.34%4.09%1.34%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in BBH

  1. Amgen Inc — 15.25%
  2. Regeneron Pharmaceuticals Inc — 6.21%
  3. Revolution Medicines Inc — 5.27%
  4. Argenx SE — 4.97%
  5. IQVIA Holdings Inc — 4.31%
  6. Alnylam Pharmaceuticals Inc — 3.83%
  7. Biogen Inc — 3.63%
  8. United Therapeutics Corp — 2.83%
  9. BeOne Medicines Ltd — 2.81%
  10. Insmed Inc — 2.67%
  11. Incyte Corp — 2.49%
  12. Neurocrine Biosciences Inc — 2.08%
  13. Icon Plc — 1.90%
  14. Charles River Laboratories International Inc — 1.50%
  15. Qiagen Nv — 1.06%

Only in GNOM

  1. Guardant Health, Inc. — 5.59%
  2. Arrowhead Pharmaceuticals, Inc. — 4.07%
  3. Legend Biotech Corp — 4.05%
  4. Praxis Precision Medicines Inc — 4.01%
  5. Twist Bioscience Corp — 3.97%
  6. CRISPR Therapeutics AG — 3.85%
  7. Veracyte Inc — 3.64%
  8. Qiagen N.V. — 3.54%
  9. 10X Genomics Inc — 3.23%
  10. Beam Therapeutics Inc — 3.09%
  11. Bnyrepos — 3.05%
  12. Eli Lilly And Company — 2.32%
  13. Ultragenyx Pharmaceutical Inc — 2.25%
  14. Caris Life Sciences, Inc. — 2.03%
  15. Genscript Biotech Corp — 2.00%

Asset mix

Asset typeBBHGNOM
Stocks100.0%99.9%
Repurchase agreements—3.1%
Cash & short-term funds0.1%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Country mix

CountryBBHGNOM
US87.3%99.1%
NL6.0%—
CH2.8%—
HK—2.0%
DE1.9%—
IE1.9%—
GB—1.8%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Check another pair

FAQ

How much do BBH and GNOM overlap?
About 23% by weight. 8 securities appear in both funds' top 25 holdings; they make up 38.2% of BBH's assets and 29.1% of GNOM's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do BBH and GNOM have in common?
The largest shared holdings are Natera Inc, Vertex Pharmaceuticals Inc, Moderna Inc, Illumina Inc, Gilead Sciences Inc.
Should I own both BBH and GNOM?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, BBH or GNOM?
GNOM is broader, with 51 positions versus 25 for BBH. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.